// App-Quantinova.ai

: Long-Term Outcome of Second Allogeneic Stem Cell Transplantation (HSCT2) for Primary Graft Failure in Patients with Acute Leukemia in Remission: A Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Researchers

Presenter

  • Arnon Nagler

Principal Investigators

  • Myriam Labopin

  • Alexander D. Kulagin

  • Andrea Velardi

  • Jaime Sanz

  • Helene Labussiere-Wallet

  • Victoria Potter

  • Jurgen Kuball

  • Simona Sica

  • Elena N. Parovichnikova

  • Wolfgang Bethge

  • Xavier Leleu

  • Uwe Platzbecker

  • Friedrich Stolzel

  • Fabio Ciceri

  • Mohamad Mohty

Medical Centers

  • University Medical Centre Dept. of Haematology, Utrecht, The Netherlands, Utrecht, Netherlands

  • EBMT Paris study office / CEREST-TC, Paris, France, Department of Hematology, Saint Antoine Hospital, Paris, France, INSERM UMR , Sorbonne University, Paris, France

  • Bone Marrow TransplantUnit, Clinical Hematology, Hopital La Miletrie, Poitiers, France

  • King's College Hospital NHS Foundation Trust, London, United Kingdom

  • Universitaetsklinikum Dresden, Medizinische Klinik und Poliklinik I, Dresden, Germany

  • Istituto di Ematologia, Universita' Cattolica del Sacro Cuore, Rome, Italy

  • Acute Leukemia Working Party of EBMT, Paris, France

  • Hematology and Bone Marrow Transplant Unit, Chaim Sheba Medical Center, Tel Hashomer, Israel

  • National Medical Research Center for Hematology, Moscow, Russian Federation

  • Hopital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France

  • Hematology & Oncology, Universitaet Tuebingen, Medizinische Klinik, Tuebingen, Germany

  • Raisa Gorbacheva Memorial Research Institute for Paediatric Oncology, Hematology, and Transplantation, First Pavlov State Medical University of St. Petersburg, St Petersburg, Russian Federation

  • Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy

  • Department of Hematology, Cell Therapy and Hemostaseology, University Hospital Leipzig, Leipzig, Germany

  • Acute Leukemia Working Party, Paris Study office, European Society for Blood and Marrow Transplantation, Paris, France

  • Sezione di Ematologia, Dipartimento di Medicina Clinica e Sperimentale, Università di Perugia, Ospedale Santa Maria della, Perugia, Italy

  • Department of Hematology, University Hospital La Fe in Valencia, Valencia, Spain

Locations

  • Netherlands

  • Germany

  • France

  • Italy

  • United States

  • Israel

  • United Kingdom

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Acute Leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved